Charity News from Thursday, Apr. 29, 2004American Cancer Society Responds to Iressa StudyAmerican Cancer Society | A study released early from the May 20, 2004 issue of the New England Journal of Medicine study suggests that a sub-group of patients diagnosed with non-small cell lung cancer are more responsive to treatment with gefitinib (trade name Iressa). Rep. Hyde Staffer Joins Catholic Relief Services Legislative Affairs Team Catholic Relief Services | Trish Katyoka, former professional staff member on the House Committee on International Relations, this week joined humanitarian organization Catholic Relief Services as Legislative Associate.
|
|
